亞洲知識產權資訊網為知識產權業界提供一個一站式網上交易平台,協助業界發掘知識產權貿易商機,並與環球知識產權業界建立聯繫。無論你是知識產權擁有者正在出售您的知識產權,或是製造商需要購買技術以提高操作效能,又或是知識產權配套服務供應商,你將會從本網站發掘到有用的知識產權貿易資訊。

Synthesis and Design of Silver Nanoparticle Embedded mPEG-PDLLA Polymersome Nanocarriers

技術優勢
The nanocarrier:ΓÇóAllows for combination of multiple drugs into one system, enabling effective treatment of complex infectionsΓÇóProvides a long lasting and time release treatment as compared to conventional systemsΓÇóHelps in effectively overcoming bacterial genetic resistance to antibioticsΓÇóAllows for release of antibiotics over several weeks, reducing the number of dosages as well as infection relapse potentialΓÇóEnables a reduced antibiotic degradation as compared to conventional systemsΓÇóAllows for an ideal particle size, enabling desirable retention time within the biological systemΓÇóWould be commercially useful for the following applications:oTreatment of life-threatening infections especially related to antibiotic resistant bacteriaoReduction in spread of bacterial generic resistance against antibioticsoElimination of persistent infectionsoMedical device/implant coatings for reducing medical device-related infections
詳細技術說明
None
*Abstract
Till date, bacterial genetic resistance to antibiotics has been a major threat to global healthcare management. Infections caused by such bacteria are extremely difficult to treat. Researchers have tried various mechanisms and technologies to overcome this issue; however, none of the existing mechanisms are really effective as they are associated with one or more limitations such as multiple dosage requirements, ineffective treatment (infection relapse) and reduced antibiotic shelf life. This invention relates to the development and use of novel, silver nanoparticles embedded polymersome nanocarriers to effectively target such antibiotic resistant bacteria.
*Principal Investigation

Name: Benjamin Geilich

Department:


Name: Thomas Webster

Department:

國家/地區
美國

欲了解更多信息,請點擊 這裡
移動設備